Parkinson's Disease - a series of reviews
Initiation and propagation of α-synuclein aggregation in the nervous system
The two main pathological hallmarks of Parkinson’s disease are loss of dopamine neurons in the substantia nigra pars compacta and proteinaceous amyloid fibrils composed mostly of α-synuclein, called Lewy patho...15:19Molecular Neurodegeneration 2020LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same
Since the discovery of leucine-rich repeat kinase 2 (LRRK2) as a protein that is likely central to the aetiology of Parkinson’s disease, a considerable amount of work has gone into uncovering its basic cellula...14:49Molecular Neurodegeneration 2019Glucocerebrosidase and its relevance to Parkinson disease
Mutations in GBA1, the gene encoding the lysosomal enzyme glucocerebrosidase, are among the most common known genetic risk factors for the development of Parkinson disease and related synucleinopathies. A great d...14:36Molecular Neurodegeneration 2019Impaired dopamine metabolism in Parkinson’s disease pathogenesis
A full understanding of Parkinson’s Disease etiopathogenesis and of the causes of the preferential vulnerability of nigrostriatal dopaminergic neurons is still an unsolved puzzle. A multiple-hit hypothesis has...14:35Molecular Neurodegeneration 2019Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Alpha-synuclein (αS) is the major constituent of Lewy bodies and a pathogenic hallmark of all synucleinopathathies, including Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atro...14:29Molecular Neurodegeneration 2019Glial phagocytic clearance in Parkinson’s disease
An emerging picture suggests that glial cells’ loss of beneficial roles or gain of toxic functions can contribute to neurodegenerative conditions. Among glial cells, microglia and astrocytes have been shown to...14:16Molecular Neurodegeneration 2019Dementia with Lewy bodies: an update and outlook
Dementia with Lewy bodies (DLB) is an age-associated neurodegenerative disorder producing progressive cognitive decline that interferes with normal life and daily activities. Neuropathologically, DLB is charac...14:5Molecular Neurodegeneration 2019Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease of the central nervous system (CNS), which affects mostly older adults. In recent years, the incidence of PD has been dramaticall...14:3Molecular Neurodegeneration 2019
No hay comentarios:
Publicar un comentario